SHERRY AZAR: Open Payments
NPI 1528050788 · ESTERO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$212 in 8 payments from 6 companies in 2025. Trend: 2023 $576 · 2024 $991 · 2025 $212
Food & beverage: $212
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $84 |
| Legend Biotech USA Inc. | 1 | $30 |
| Lilly USA, LLC | 1 | $28 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| BeiGene USA, Inc. | 1 | $27 |
| TAIHO ONCOLOGY, INC. | 1 | $15 |
Products named: FRUZAQLA, CARVYKTI, VERZENIO, Fabhalta, NINLARO, BRUKINSA, VPRIV, LONSURF.
Industry payments across FL — which companies pay providers there.
